Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-09
2007-10-09
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S385000, C549S390000
Reexamination Certificate
active
10549106
ABSTRACT:
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor ? agonists. Such agonists are useful for the treating Estrogen Receptor ? mediated diseases such as prostate cancer or BPH.
REFERENCES:
patent: 6630508 (2003-10-01), Dodge et al.
patent: 2 361 642 (2001-10-01), None
patent: WO 97/09348 (1996-09-01), None
patent: WO 99/02512 (1999-01-01), None
patent: WO 01/49673 (2001-07-01), None
patent: WO 01/64665 (2001-09-01), None
patent: WO 01/72713 (2001-10-01), None
patent: WO 03/044006 (2003-05-01), None
patent: WO 03/051805 (2003-06-01), None
Anderson, et al., “Synthesis of 6,9-bisnormethyl-8-methoxy-12,13-epoxy-6,8,10-trichothec atriene,” Journal of Organic Chemistry, American Chemisal Society, Easton, U.S., vol. 42, No. 6, pp. 1045-1050 (1977).
Oude-Alink, et al., “Photolysis of 2-keto-2,3-dihydrobenzofurans, o-hydroxystyrenes and 1-o-hydroxyphenyl)-1,5-hexadienes,” Journal of Organic Chemistry, American Chemical Society, Easton, U.S., vol. 38, No. 11, pp. 1993-2001 (1973).
Shrestha, et al., “Facile synthesis of the fused 6-6-5 ring system containing chroman ring from 2-(1-hydroxy-5-alkenyl)phenol derivatives via intramolecular inverse-electron-demanddiels-alder reaction,” Bulletin of the Chemical Society of Japan, Japan Publications Trading Co., Tokyl, JP, vol. 72, No. 1, pp. 73-83 (1999).
Welhua, et al., “A role for estrogen receptor β in the regulation of growth of the ventral prostate,” PNAS, vol. 98, No. 11, pp. 6330-6335 (2001).
Mortensen, et al., “Synthesis and biological evaluation of a novel series of furans: ligands selectic for estrogen receptor α,” Journal of Medicinal Chemistry, A-K, Page Est. 10:8 (2001).
Meyers, “Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues,” Journal of Medicinal Chemistry, A-V, Page Est. 21:3 (2001).
Durst Gregory Lee
Norman Bryan Hurst
Pfeifer Lance Allen
Richardson Timothy Ivo
Demeter John C.
Dentz Bernard
Eli Lilly and Company
LandOfFree
Substituted benzopyrans as selective estrogen receptor-beta... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzopyrans as selective estrogen receptor-beta..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzopyrans as selective estrogen receptor-beta... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3864311